Crystalline Arthropathies - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Crystalline Arthropathies

Description:

Uric Acid by product of Purine metabolism ... Heredity. Pharm Agents. Salicylates. Diuretics. Cyclosporine. Gout. Two Main Classifications ... – PowerPoint PPT presentation

Number of Views:210
Avg rating:3.0/5.0
Slides: 27
Provided by: walterei
Category:

less

Transcript and Presenter's Notes

Title: Crystalline Arthropathies


1
Crystalline Arthropathies
  • Walter Eisenhauer MMSc, PA-C

2
Gout
  • The Disease of Kings, The King of Diseases
  • Predominately disease of adult men
  • Females spared until postmenopause
  • Uric Acid by product of Purine metabolism
  • 10 of those with gout overproduce- the remaining
    90 are underexcretors

3
Gout
  • Urates circulate in plasma mainly in unbound form
  • Referred to as urate pool
  • Pool increases as Uric acid levels increase
  • Excreted by two mechanisms
  • Renal
  • Bacterial oxidation in the gut

4
Gout
  • Total Body urate Pool 1200 mg males/600 mg
    females
  • 85 denovo synthesis
  • 15 dietary intake of purines
  • Purine restricted diet may only decrease serum
    urate level by 1-1.2 mg/dl
  • 50-60 urate pool turns over each day

5
Gout
  • Urate complete filtration
  • Presecretory tubular resorption 99
  • Tubular excretion 50
  • Post secretory resorption 80
  • Excretion of 10 filtered load (600 mg/day)
  • Additional 1/3 excreted by pancreatic and
    intestinal juices

6
Gout
  • Influenced by
  • Heredity
  • Pharm Agents
  • Salicylates
  • Diuretics
  • Cyclosporine

7
Gout
  • Two Main Classifications
  • Overproducers
  • Under Excreters

8
Gout
  • Overproducers
  • 10
  • Primary
  • Idiopathic
  • Enzyme abnormalities in purine metabolism
  • Secondary
  • Excessive dietary uptake
  • Myeloproliferative disorders
  • Severe muscle exertion

9
Gout
  • Decreased excretion- 90
  • Primary Vs Secondary
  • Primary
  • Unidentified defect in tubular secretion ( up to
    40 less)

10
Gout
  • Secondary
  • Renal insufficiency
  • Diuretics
  • Low dose ASA
  • Cyclosporine
  • Ethambutol
  • Lead toxicity
  • Saturnine gout due to nephropathy
  • DKA
  • Starvation
  • Ketosis
  • Ethanol
  • Lactic acidosis
  • Predisposing illness- HTN, DM etc
  • Combined ETOH/G6PD deficiency

11
Gout
  • Urate Pool substantially enlarged in Gout
  • Non Tophaceous- 2-4gm
  • Tophaceous 30 gm or more

12
Gout
  • Urate solubility
  • At physiologic ph 99 as urate not uric acid
  • Soluability at 37degrees is 7.0 vs 30 degrees is
    4.5 mg/dl
  • Intrarticular temp at the knee is 33 degrees-
    ankle 29 degrees

13
Gout
  • Acute Gout clinical features
  • Males 4th-6th decade
  • Consider enzyme abnormality if before 60
  • 38 with normal uric acid
  • Monoarticular 85-90
  • Podagra in 50, ultimately 90
  • Primarily lower extremity joints
  • Precipitated by
  • Surgery
  • Trauma
  • Febrile Illness
  • Excessive eating or ETOH consumption

14
Gout
  • Systemic symptoms in polyarticular forms
  • Fever
  • Chills
  • Elevated WBC/ESR
  • Spontaneous resolution over days to weeks
  • Females older, post menopausal

15
Gout
  • Intercritical gout
  • 7-10 only experience initial attack
  • 62 with second attack within 1 year
  • Majority with attack within 6-24 months
  • Ultimately attacks more frequent and polyarticular

16
Gout
  • Tophaceous Gout
  • 3-21 develop
  • Average 11.6 years after initial episode
  • Typically ear, elbows, fingers, Achilles tendons
    but may appear anywhere
  • Synovial tophi can lead to bone erosions

17
Gout
  • Transplant Gout
  • Primarily related to cyclosporine
  • Acute gout often after one year
  • Tophaceous gout within 5 years
  • 13 decrease in ADLs secondary to gout

18
Gout
  • Renal Manifestations
  • Stones presenting manifestation of up to 1/3
  • Gouty Nephropathy-inter parenchymal deposits of
    monosodium urate crystals causing inflammation
    and scarring
  • Acute Uric Acid Nephropathy caused by obstruction
    of tubules with uric acid crystals

19
Gout
  • Diagnosis
  • Can not make dx with blood studies
  • Demonstrate crystals in synovial fluid
  • Presence of tophi
  • Presumptive on basis of clinical presentation
  • Strongly negative birefringent, needle shaped,
    often intracellular crystals

20
Gout
  • Xray
  • Punched out lesions
  • Asymmetric nodular soft tissue swelling
  • Joint space narrowing- often asymmetric

21
Gout
  • Treatment
  • Acute
  • Colchicine
  • 0.6 mg each hour up to 8.0mg
  • 80 response within 48 hours
  • 91 with GI Toxicity
  • Iv Colchicine
  • 1-3 mg diluted in 20 ml of D5W through good IV
    access
  • No additional colchicine for 7 days
  • Avoid in renal/hepatic insufficiency
  • Avoid with concurrent erythromycin or cimetadine
  • Toxicity includes marrow suppression, DIC,
    hypotension, myopathy, localized phlebitis

22
Gout
  • Indomethacin
  • 50 mg TID
  • Difficult to use in PUD, Renal, Hepatic
    insufficiency
  • Corticosteroids
  • Tapering course of PO prednisone
  • Intrarticular
  • ACTH

23
Gout
  • Prophy
  • Colchicine 0.6mg BID
  • Effective in 80-90
  • Use for 1-2 weeks before initiating Uric Acid
    Lowering agents

24
Gout
  • Hypouricemic therapy
  • Indications
  • Tophaceous gout
  • Recurrent attacks
  • 24 hour urine is useful in determining choice of
    agents
  • Under-excretor gets probenicid or sulfinpyrazone
  • Overproducer-Allipurinol

25
Gout
  • Asymptomatic Hyperuricemia
  • Treat only when gt 13 mg/dl

26
Pseudogout
  • CPPD- Calcium Pyrophosphate Dihydrate
  • Chondrocalcinosis when calcium in cartilage
  • Mimics presentation of Gout attacks
  • Treat with NSAIDS
  • Rule out Hyperparathyroidism
Write a Comment
User Comments (0)
About PowerShow.com